Results 121 to 130 of about 6,176 (214)

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project. [PDF]

open access: yesCancers (Basel)
Abruzzese E   +31 more
europepmc   +1 more source

Monografie. La Facoltà di Architettura "Aldo Rossi" a Cesena.

open access: yes, 2008
Il volume raccoglie le ricerche svolte all'interno della Facoltà di Architettura "Aldo Rossi" dell'Università di Bologna - sede di ...
I. Clemente
core  

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience. [PDF]

open access: yesInt J Cardiol Cardiovasc Risk Prev
Catapano AL   +6 more
europepmc   +1 more source

Aldo Rossi. Il Teatro del Mondo 1979-2004

open access: yes, 2004
Documentario video sul Teatro del Mondo di Aldo Rossi ricostruito in occasione della mostra Arti & Architettura tenutasi a ...
FERA, FRANCESCO SAVERIO, D. Zanasi
core  

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis). [PDF]

open access: yesDermatol Ther (Heidelb)
Trovato E   +33 more
europepmc   +1 more source

Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. [PDF]

open access: yesAnn Hematol
Conticello C   +43 more
europepmc   +1 more source

Correction: Castagna et al. Sodium Chloride Cotransporter in Hypertension. <i>Biomedicines</i> 2024, <i>12</i>, 2580. [PDF]

open access: yesBiomedicines
Castagna A   +6 more
europepmc   +1 more source

Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care? [PDF]

open access: yesAnn Hematol
Tarantini F   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy